Trial
NCT05156034
A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Sarkana Pharma Inc
Collaborators
—
Condition
Healthy Participants
Intervention
SRK-001
Why stopped
Due to occurrence of eye related adverse events.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-13